---
agency: Department of Health and Human Services
applicant_types:
- Individual/Family
- Local (includes State-designated lndian Tribes, excludes institutions of higher
  education and hospitals
- Private nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Public nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Small business (less than 500 employees)
assistance_types:
- Project Grants
beneficiary_types:
- Individual/Family
- Private nonprofit institution/organization
- Profit organization
- Public nonprofit institution/organization
- Small business
categories:
- Health
- Health - Prevention and Control
- Health - Specialized Health Research and Training
cfda: '93.839'
fiscal_year: '2022'
layout: program
objective: 'The Division of Blood Diseases and Resources supports research and research
  training on the pathophysiology, diagnosis, treatment, and prevention of non-malignant
  blood diseases, including anemias, sickle cell disease, thalassemia; leukocyte biology,
  pre-malignant processes such as  myelodysplasia and myeloproliferative disorders;
  hemophilia and other abnormalities of hemostasis and thrombosis; and immune dysfunction.  Funding
  encompasses a broad spectrum of hematologic inquiry, ranging from stem cell biology
  to medical management of blood diseases and to assuring the adequacy and safety
  of the nation''s blood supply.  Programs also support the development of novel cell-based
  therapies to bring the expertise of transfusion medicine and stem cell technology
  to the repair and regeneration of human tissues and organs. Small Business Innovation
  Research (SBIR) program: To stimulate technological innovation; use small business
  to meet Federal research and development needs; foster and encourage participation
  in innovation and entrepreneurship by socially and economically disadvantaged persons;
  and increase private-sector commercialization of innovations derived from Federal
  research and development funding. Small Business Technology Transfer (STTR) program:
  To stimulate technological innovation; foster technology transfer through cooperative
  R&D between small businesses and research institutions, and increase private sector
  commercialization of innovations derived from federal R&D.'
obligations: '[{"key":"SAM.gov Estimate","year":"2019","amount":0.0},{"key":"SAM.gov
  Actual","year":"2019","amount":0.0},{"key":"USASpending.gov Obligations","year":"2019","amount":389659041.0},{"key":"SAM.gov
  Estimate","year":"2020","amount":0.0},{"key":"SAM.gov Actual","year":"2020","amount":439590904.0},{"key":"USASpending.gov
  Obligations","year":"2020","amount":439590904.0},{"key":"SAM.gov Estimate","year":"2021","amount":442062419.0},{"key":"SAM.gov
  Actual","year":"2021","amount":411501594.0},{"key":"USASpending.gov Obligations","year":"2021","amount":0.0},{"key":"SAM.gov
  Estimate","year":"2022","amount":429798353.0},{"key":"SAM.gov Actual","year":"2022","amount":446702126.0},{"key":"USASpending.gov
  Obligations","year":"2022","amount":0.0},{"key":"SAM.gov Estimate","year":"2023","amount":461889998.0},{"key":"SAM.gov
  Actual","year":"2023","amount":0.0},{"key":"USASpending.gov Obligations","year":"2023","amount":0.0}]'
permalink: /program/93.839.html
sub-agency: National Institutes of Health
title: Blood Diseases and Resources Research
---
